Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects

NCT00606359 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Orthomyxoviridae Infections

Interventions

BIOLOGICAL: Inactivated, split-virion influenza virus
BIOLOGICAL: Inactivated, split-virion influenza virus

Sponsor

Sanofi Pasteur, a Sanofi Company